Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases|March 19, 2024
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritisAndreas Kerschbaumer, Josef S Smolen, Ricardo J O Ferreira, et al.
Plos One|November 30, 2022
The greatest air quality experiment ever: Policy suggestions from the COVID-19 lockdown in twelve European citiesMarialuisa Volta, Umberto Giostra, Giorgio Guariso, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Rheumatology (Oxford, England)|November 18, 2021
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritisPaul Studenic, Gregor Bond, Andreas Kerschbaumer, et al.
Trials|March 24, 2026
An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trialKarolina Anderle, Daniela Sieghart, Martina Durechova, et al.
Annals of the Rheumatic Diseases|November 14, 2022
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|November 11, 2022
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|November 21, 2022
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisSytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|April 8, 2026
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritisFaidra Laskou, Victoria Konzett, Josef S Smolen, et al.
Pageof 6